We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Drs. Ko and Cubb discuss the ‘eye vitals’ that endocrine and general eye care providers could examine in patients with thyroid eye disease (TED), and discuss how a euthyroid patient with TED that underwent and failed multiple steroid bursts was eventually successfully treated with teprotumumab.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Trisha Cubb, MD, FACE, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Horizon Therapeutics.
Audrey Ko, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Tarsus Pharmaceuticals. Grant/Research Support: Thrive Health. Speaker's Bureau: Horizon Therapeutics.
The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.
Upon completion of this activity, the participant should be able to:
This certified continuing education activity is designed for comprehensive ophthalmologists, optometrists, primary care physicians, and endocrinology advanced practice providers.
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Evolve Medical Education LLC (Evolve) is a leader in cultivating health care for patients by educating clinical competence of the health care team. Evolve achieves this by developing and distributing high-quality, evidence-based, valid, independent CME/CE activities in a variety of learning formats. These activities are designed to increase clinician’s knowledge, skills, competence and professional performance as well as to promote professional growth, maintenance of licensure, and support quality change in care of patients.
This activity is supported by an unrestricted educational grant from Horizon Therapeutics.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Horizon Therapeutics.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Release Date:
Expiration Date:
Drs. Ko and Cubb discuss the ‘eye vitals’ that endocrine and general eye care providers could examine in patients with thyroid eye disease (TED), and discuss how a euthyroid patient with TED that underwent and failed multiple steroid bursts was eventually successfully treated with teprotumumab.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Trisha Cubb, MD, FACE, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Horizon Therapeutics.
Audrey Ko, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Tarsus Pharmaceuticals. Grant/Research Support: Thrive Health. Speaker's Bureau: Horizon Therapeutics.
The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.
Upon completion of this activity, the participant should be able to:
This certified continuing education activity is designed for comprehensive ophthalmologists, optometrists, primary care physicians, and endocrinology advanced practice providers.
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Evolve Medical Education LLC (Evolve) is a leader in cultivating health care for patients by educating clinical competence of the health care team. Evolve achieves this by developing and distributing high-quality, evidence-based, valid, independent CME/CE activities in a variety of learning formats. These activities are designed to increase clinician’s knowledge, skills, competence and professional performance as well as to promote professional growth, maintenance of licensure, and support quality change in care of patients.
This activity is supported by an unrestricted educational grant from Horizon Therapeutics.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Horizon Therapeutics.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Release Date:
Expiration Date:
Stay current with the best on medical education
